
Insulet Corporation is a global leader in innovative, wearable insulin delivery systems, dedicated to simplifying diabetes management through its Omnipod technology and headquartered in Acton, Massachusetts.
Import Shipments
Distribution Centers
Annual Revenue
Founded
Insulet is likely focused on expanding its Omnipod product line, enhancing digital health integration, and increasing global market penetration in response to rising diabetes prevalence and demand for wearable medical technology.
Launch of next-generation Omnipod devices with improved connectivity and automation
Strategic efforts to expand market presence and reach new customer segments.
Implementation of advanced technologies to improve service delivery and customer experience.
Insulet Corporation designs, manufactures, and markets the Omnipod Insulin Management System, a revolutionary tubeless and wireless insulin pump that provides continuous insulin delivery for up to three days. The company’s mission is to improve the lives of people with diabetes and reduce the burden of daily management through advanced, user-friendly technology. Insulet operates highly automated manufacturing facilities and maintains a significant global workforce to support its expanding customer base. The company also explores the application of its pod-based technology for other subcutaneous drug delivery needs.